Evaluating medicine prices, availability and affordability in Bangladesh using World Health Organisation and Health Action International methodology

Lombe Kasonde, David Tordrup, Aliya Naheed, Wu Zeng, Shyfuddin Ahmed, Zaheer-Ud-Din Babar

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background
Previous studies have shown limited availability of medicines in health facilities in Bangladesh. While medicines are dispensed for free in public facilities, they are paid out-of-pocket in private pharmacies. Availability, price and affordability are key concerns for access to medicines in Bangladesh.

Methods
The World Health Organization/Health Action International survey methodology was used to determine price, availability and affordability of 61 lowest price generic (LPG) and originator branded medicines in public facilities, private retail pharmacies and private clinics across 6 regions of Bangladesh. Medicines for non-communicable and infectious diseases, and both on and off the national Essential Medicines List were included. Prices were compared internationally using Median Price Ratio (MPR).

Results
Mean LPG (originator brand) availability in the public sector, private retail pharmacies, and private clinics was 37%, 63 (4) percent, and 54 (2) percent, respectively. Medicines for Non-Communicable Diseases (NCD) and essential medicines were significantly less available than infectious disease medicines and non-essential medicines, respectively.

Mean LPG (originator brand) MPR was 0.977 in the public sector, 1.700 (3.698) in private retail pharmacies and 1.740 (3.758) in private clinics. Six medicines were expensive by international standards across all sectors.

The least affordable treatments in both private sectors were bisoprolol (hypertension), metformin (diabetes) and atorvastatin (hypercholesterolemia).

Conclusion
Availability and affordability of NCD medicines are key concerns where the burden of NCD is rising. These findings show improvement from earlier studies, but room for further advances in availability and affordability of NCD medicines in Bangladesh. A small number of medicines are consistently expensive across sectors in Bangladesh, suggesting the need for strategies to address prices for certain medicines
Original languageEnglish
Article number383
Pages (from-to)1-12
Number of pages12
JournalBMC Health Services Research
Volume19
Issue number1
DOIs
Publication statusPublished - 13 Jun 2019

Fingerprint

Bangladesh
Medicine
Health
Pharmacies
Public Facilities
Public Sector
Infectious Disease Medicine
Bisoprolol
Private Sector
Metformin
Health Facilities
Hypercholesterolemia
Communicable Diseases
Hypertension

Cite this

@article{11bd63063b0a4c618cd9a6d3c08e1380,
title = "Evaluating medicine prices, availability and affordability in Bangladesh using World Health Organisation and Health Action International methodology",
abstract = "BackgroundPrevious studies have shown limited availability of medicines in health facilities in Bangladesh. While medicines are dispensed for free in public facilities, they are paid out-of-pocket in private pharmacies. Availability, price and affordability are key concerns for access to medicines in Bangladesh.MethodsThe World Health Organization/Health Action International survey methodology was used to determine price, availability and affordability of 61 lowest price generic (LPG) and originator branded medicines in public facilities, private retail pharmacies and private clinics across 6 regions of Bangladesh. Medicines for non-communicable and infectious diseases, and both on and off the national Essential Medicines List were included. Prices were compared internationally using Median Price Ratio (MPR).ResultsMean LPG (originator brand) availability in the public sector, private retail pharmacies, and private clinics was 37{\%}, 63 (4) percent, and 54 (2) percent, respectively. Medicines for Non-Communicable Diseases (NCD) and essential medicines were significantly less available than infectious disease medicines and non-essential medicines, respectively.Mean LPG (originator brand) MPR was 0.977 in the public sector, 1.700 (3.698) in private retail pharmacies and 1.740 (3.758) in private clinics. Six medicines were expensive by international standards across all sectors.The least affordable treatments in both private sectors were bisoprolol (hypertension), metformin (diabetes) and atorvastatin (hypercholesterolemia).ConclusionAvailability and affordability of NCD medicines are key concerns where the burden of NCD is rising. These findings show improvement from earlier studies, but room for further advances in availability and affordability of NCD medicines in Bangladesh. A small number of medicines are consistently expensive across sectors in Bangladesh, suggesting the need for strategies to address prices for certain medicines",
author = "Lombe Kasonde and David Tordrup and Aliya Naheed and Wu Zeng and Shyfuddin Ahmed and Zaheer-Ud-Din Babar",
year = "2019",
month = "6",
day = "13",
doi = "10.1186/s12913-019-4221-z",
language = "English",
volume = "19",
pages = "1--12",
journal = "BMC Health Services Research",
issn = "1472-6963",
publisher = "BioMed Central",
number = "1",

}

Evaluating medicine prices, availability and affordability in Bangladesh using World Health Organisation and Health Action International methodology. / Kasonde, Lombe; Tordrup, David; Naheed, Aliya; Zeng, Wu; Ahmed, Shyfuddin; Babar, Zaheer-Ud-Din.

In: BMC Health Services Research, Vol. 19, No. 1, 383, 13.06.2019, p. 1-12.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Evaluating medicine prices, availability and affordability in Bangladesh using World Health Organisation and Health Action International methodology

AU - Kasonde, Lombe

AU - Tordrup, David

AU - Naheed, Aliya

AU - Zeng, Wu

AU - Ahmed, Shyfuddin

AU - Babar, Zaheer-Ud-Din

PY - 2019/6/13

Y1 - 2019/6/13

N2 - BackgroundPrevious studies have shown limited availability of medicines in health facilities in Bangladesh. While medicines are dispensed for free in public facilities, they are paid out-of-pocket in private pharmacies. Availability, price and affordability are key concerns for access to medicines in Bangladesh.MethodsThe World Health Organization/Health Action International survey methodology was used to determine price, availability and affordability of 61 lowest price generic (LPG) and originator branded medicines in public facilities, private retail pharmacies and private clinics across 6 regions of Bangladesh. Medicines for non-communicable and infectious diseases, and both on and off the national Essential Medicines List were included. Prices were compared internationally using Median Price Ratio (MPR).ResultsMean LPG (originator brand) availability in the public sector, private retail pharmacies, and private clinics was 37%, 63 (4) percent, and 54 (2) percent, respectively. Medicines for Non-Communicable Diseases (NCD) and essential medicines were significantly less available than infectious disease medicines and non-essential medicines, respectively.Mean LPG (originator brand) MPR was 0.977 in the public sector, 1.700 (3.698) in private retail pharmacies and 1.740 (3.758) in private clinics. Six medicines were expensive by international standards across all sectors.The least affordable treatments in both private sectors were bisoprolol (hypertension), metformin (diabetes) and atorvastatin (hypercholesterolemia).ConclusionAvailability and affordability of NCD medicines are key concerns where the burden of NCD is rising. These findings show improvement from earlier studies, but room for further advances in availability and affordability of NCD medicines in Bangladesh. A small number of medicines are consistently expensive across sectors in Bangladesh, suggesting the need for strategies to address prices for certain medicines

AB - BackgroundPrevious studies have shown limited availability of medicines in health facilities in Bangladesh. While medicines are dispensed for free in public facilities, they are paid out-of-pocket in private pharmacies. Availability, price and affordability are key concerns for access to medicines in Bangladesh.MethodsThe World Health Organization/Health Action International survey methodology was used to determine price, availability and affordability of 61 lowest price generic (LPG) and originator branded medicines in public facilities, private retail pharmacies and private clinics across 6 regions of Bangladesh. Medicines for non-communicable and infectious diseases, and both on and off the national Essential Medicines List were included. Prices were compared internationally using Median Price Ratio (MPR).ResultsMean LPG (originator brand) availability in the public sector, private retail pharmacies, and private clinics was 37%, 63 (4) percent, and 54 (2) percent, respectively. Medicines for Non-Communicable Diseases (NCD) and essential medicines were significantly less available than infectious disease medicines and non-essential medicines, respectively.Mean LPG (originator brand) MPR was 0.977 in the public sector, 1.700 (3.698) in private retail pharmacies and 1.740 (3.758) in private clinics. Six medicines were expensive by international standards across all sectors.The least affordable treatments in both private sectors were bisoprolol (hypertension), metformin (diabetes) and atorvastatin (hypercholesterolemia).ConclusionAvailability and affordability of NCD medicines are key concerns where the burden of NCD is rising. These findings show improvement from earlier studies, but room for further advances in availability and affordability of NCD medicines in Bangladesh. A small number of medicines are consistently expensive across sectors in Bangladesh, suggesting the need for strategies to address prices for certain medicines

UR - http://www.scopus.com/inward/record.url?scp=85067301343&partnerID=8YFLogxK

U2 - 10.1186/s12913-019-4221-z

DO - 10.1186/s12913-019-4221-z

M3 - Article

VL - 19

SP - 1

EP - 12

JO - BMC Health Services Research

JF - BMC Health Services Research

SN - 1472-6963

IS - 1

M1 - 383

ER -